Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-up Registry of Patients With CODMAN CERTAS Plus Programmable Valves

NCT04207229 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT04207229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04207229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-up Registry of Patients With CODMAN CERTAS Plus Programmable Valves
Lead sponsor
Integra LifeSciences Corporation
Phase
Observational
Overall status
Completed
Start date
November 21, 2019
Completion date
November 18, 2021
Enrollment
35 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hydrocephalus, iih - idiopathic intracranial hypertension, nph (normal pressure hydrocephalus)